Page 127 - NobleCon20-Book-Project

Nutriband Inc.

SELECTED FINANCIAL ITEMS NTRB

(in millions of USD)
CQ4 '23 CQ1 '24 CQ2 '24 CQ3 '24 LTM
Income Statement Key Items
Total Revenue 0.43 0.52 0.41 0.44 1.80
Gross Profit 0.16 0.18 0.16 0.10 0.61
Gross Margin 37% 35% 40% 23% 34%
EBIT (1.72) (1.31) (1.89) (1.41) (6.33)
EBIT Margin -403% -249% -463% -318% -351%
Net Income to Common Shareholders (1.76) (1.88) (1.90) (1.71) (7.24)
Net Margin -411% -359% -465% -385% -402%

Balance Sheet Key Items
Total Assets 8.52 7.52 15.15 13.63 13.63
Cash & Short Term Investments 1.27 0.49 8.35 6.76 6.76
% of Assets 15% 7% 55% 50% 50%
Current Assets -Total 2.00 1.02 8.73 7.25 7.25
% of Assets 23% 14% 58% 53% 53%
Total Liabilities 2.81 1.08 1.79 1.17 1.17
% of Assets 33% 14% 12% 9% 9%
Current Liabilities - Total 0.72 1.00 1.42 1.10 1.10
% of Assets 8% 13% 9% 8% 8%
Long Term Debt 2.09 0.08 0.37 0.07 0.07
% of Assets 24% 1% 2% 1% 1%
Total Equity 5.71 6.44 13.36 12.46 12.46
% of Assets 67% 86% 88% 91% 91%

Cash Flow Statement Key Items
Net Cash Flow - Operating Activities (1.06) (0.72) (0.83) (1.54) (4.16)
Net Cash Flow - Investing 0.00 (0.05) (0.01) (0.04) (0.09)
Net Cash Flow - Financing (0.00) (0.01) 8.69 (0.01) 8.68

Source: Capital IQ

PRICE / VOLUME

Source: Channelchek/QuoteMedia

Noble Capital Markets' Twentieth Annual Small & Microcap Investor Conference